Reported first quarter year-over-year revenue growth of 3.4% Company reiterates full-year 2026 guidance BEVERLY, Mass. — Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results …
Reported first quarter year-over-year revenue growth of 3.4% Company reiterates full-year 2026 guidance BEVERLY, Mass. — Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products …